Friday, March 11, 2022, 9:00 AM – Monday, March 14, 2022, 1:00 PM EST

This four-day live course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Each lecture will conclude with a live Q&A with esteemed MSK course faculty.

Additionally, registered attendees will receive access to an online course syllabus, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course.

Who Should Attend

The target audience for this well-received annual program includes medical oncology professionals – physicians, nurses, pharmacists, fellows and residents.

1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers
2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
3. Prepare for ABIM examinations in medical oncology and hematology

Objectives

– Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers

– Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice

– Prepare for ABIM examinations in medical oncology and hematology

Program : 

SOLID TUMOR SESSION
Colon Cancer Leonard B. Saltz, MD

Melanoma Paul B. Chapman, MD

Prostate Cancer Susan F. Slovin, MD, PhD

Kidney Cancer Robert J. Motzer, MD

Urothelial Cancer Gopa Iyer, MD

Testis Cancer Darren R. Feldman, MD

Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD

Ovarian Cancer Rachel N. Grisham, MD

Breast Cancer: Surgery Hiram S. Cody III, MD, FACS

Breast Cancer: Radiation Therapy Beryl McCormick, MD, FACR

Genetics Zsofia K. Stadler, MD

Small Cell Lung Cancer W. Victoria Lai, MD

Breast Cancer: Adjuvant Therapy Chau T. Dang, MD

Breast Cancer: Advanced Disease Rachel Sanford, MD

Breast Cancer: Hormonal Therapy Julia Brockway-Marchello, MD

Carcinoma of Unknown Primary Anna M. Varghese, MD

Hepatocellular Cancer and Cholangiocarcinoma Ghassan K. Abou-Alfa, MD, MBA

Pancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD

Non Small Cell Lung Cancer Gregory J. Riely, MD, PhD

Head and Neck, Thyroid,

Non-melanoma Skin Cancer

Lara A. Dunn, MD

Anal/Rectal Cancer Andrea Cercek, MD

Esophageal/Gastric Cancer David H. Ilson, MD, PhD, FACP, FASCO

CNS Tumors Christian Grommes, MD

Sarcoma Mark A. Dickson, MD

Infectious Disease Susan K. Seo, MD

Mesothelioma Marjorie G. Zauderer, MD

Pharmacology Mrinal M. Gounder, MD

MALIGNANT HEMATOLOGY SESSION

CAR T cells Michael Scordo, MD

Low Grade NHL Andrew D. Zelenetz, MD, PhD

CLL/SLL Lindsey Roeker, MD

DLBCL/MCL/BL Paul Hamlin, MD

HL/T Cell Alison J. Moskowitz, MD

Auto/Allo Gunjan Shah, MD

ALL Mark Blaine Geyer, MD

AML Eytan Stein, MD

MDS/MPN Michael J. Mauro, MD

Myeloma/Amyloid Malin Hultcrantz

BENIGN HEMATOLOGY SESSION

Approach to The Bleeding Patient Rekha Paramewaran, MD

The Role of the New Direct Oral Anticoagulants in Practice

Simon Mantha, MD, MPH

Thrombocytopenia, ITP and Beyond Cy Wilkins, MD

Sickle Cell Disease, Thalassemia Jodi Mones, MD

Recorded/Review Date: March 11-14, 2022;

Original Release Date: April 4, 2022;